Michael L Blute, MD - Medicare Urology in Boston, MA

Michael L Blute, MD is a medicare enrolled "Urology" physician in Boston, Massachusetts. He went to Creighton University School Of Medicine and graduated in 1982 and has 42 years of diverse experience with area of expertise as Urology. He is a member of the group practice Massachusetts General Physicians Organization Inc and his current practice location is 15 Parkman St, Wang 528, Boston, Massachusetts. You can reach out to his office (for appointments etc.) via phone at (617) 726-4530.

Michael L Blute is licensed to practice in Massachusetts (license number 242751) and he also participates in the medicare program. He accepts medicare assignments (which means he accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance) and his NPI Number is 1437120037.

Contact Information

Michael L Blute, MD
15 Parkman St, Wang 528,
Boston, MA 02114-3117
(617) 726-4530
(617) 726-6131



Physician's Profile

Full NameMichael L Blute
GenderMale
SpecialityUrology
Experience42 Years
Location15 Parkman St, Boston, Massachusetts
Accepts Medicare AssignmentsYes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance.
  Medical Education and Training:
  • Michael L Blute attended and graduated from Creighton University School Of Medicine in 1982
  NPI Data:
  • NPI Number: 1437120037
  • Provider Enumeration Date: 01/31/2006
  • Last Update Date: 11/25/2015
  Medicare PECOS Information:
  • PECOS PAC ID: 8123020120
  • Enrollment ID: I20100312000063

Medical Identifiers

Medical identifiers for Michael L Blute such as npi, medicare ID, medicare PIN, medicaid, etc.
IdentifierTypeStateIssuer
1437120037NPI-NPPES
219720100MedicaidMN

Medical Taxonomies and Licenses

TaxonomyTypeLicense (State)Status
208800000XUrology 27812 (Minnesota)Secondary
208800000XUrology 242751 (Massachusetts)Primary

Medical Facilities Affiliation

Facility NameLocationFacility Type
Partners Healthcare At Home - Home CareWaltham, MAHome health agency
Massachusetts General HospitalBoston, MAHospital

Group Practice Association

Group Practice NameGroup PECOS PAC IDNo. of Members
Massachusetts General Physicians Organization Inc24663658203085

News Archive

Researchers find potential therapeutic strategy to treat Alzheimer's

Researchers from the Institute of Neurosciences of the University of Barcelona (UBNeuro) have identified a potential therapeutic strategy to treat Alzheimer's, according to a study published in Journal of Neuroscience.

Different molecular mechanisms in suprachiasmatic nucleus linked to jet lag differences

It's no secret that long-distance, west-to-east air travel - Seattle to Paris, for example - can raise havoc with a person's sleep and waking patterns, and that the effects are substantially less pronounced when traveling in the opposite direction.

Canadian and Israeli researchers join forces for new research program

The Joint Canada-Israel Health Research Program is a seven-year, CA$35 million partnership between the Azrieli Foundation, Canada's International Development Research Centre, the Canadian Institutes of Health Research, and the Israel Science Foundation that draws on the scientific strengths of Canadian and Israeli researchers in the broad field of biomedicine.

Clonidine Topical Gel fails to meet primary endpoint in Phase 3 study for treatment of painful diabetic neuropathy

BioDelivery Sciences International, Inc. announced that the primary efficacy endpoint in the Phase 3 clinical study of Clonidine Topical Gel compared to placebo for the treatment of painful diabetic neuropathy did not meet statistical significance, although certain secondary endpoints showed statistically significant improvement over placebo. In addition, a strong safety profile for the product was observed.

Research shows harmful effects of chemicals in vaping liquids to lung tissue

New research appearing in the journal Scientific Reports unpacks the list of chemicals that comprise flavored e-liquids and pods used in vaping and details their harmful effects to lung tissue, including inflammation and genetic damage that could indicate long-term risk for respiratory disease and even cancer.

Read more Medical News

› Verified 2 days ago

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Medicare reassignment of benefits is a mechanism by which practitioners allow third parties to bill and receive payment for medicare services performed by them. Michael L Blute allows following entities to bill medicare on his behalf.
Entity NameMassachusetts General Physicians Organization Inc
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1801874573
PECOS PAC ID: 2466365820
Enrollment ID: O20031111000434

News Archive

Researchers find potential therapeutic strategy to treat Alzheimer's

Researchers from the Institute of Neurosciences of the University of Barcelona (UBNeuro) have identified a potential therapeutic strategy to treat Alzheimer's, according to a study published in Journal of Neuroscience.

Different molecular mechanisms in suprachiasmatic nucleus linked to jet lag differences

It's no secret that long-distance, west-to-east air travel - Seattle to Paris, for example - can raise havoc with a person's sleep and waking patterns, and that the effects are substantially less pronounced when traveling in the opposite direction.

Canadian and Israeli researchers join forces for new research program

The Joint Canada-Israel Health Research Program is a seven-year, CA$35 million partnership between the Azrieli Foundation, Canada's International Development Research Centre, the Canadian Institutes of Health Research, and the Israel Science Foundation that draws on the scientific strengths of Canadian and Israeli researchers in the broad field of biomedicine.

Clonidine Topical Gel fails to meet primary endpoint in Phase 3 study for treatment of painful diabetic neuropathy

BioDelivery Sciences International, Inc. announced that the primary efficacy endpoint in the Phase 3 clinical study of Clonidine Topical Gel compared to placebo for the treatment of painful diabetic neuropathy did not meet statistical significance, although certain secondary endpoints showed statistically significant improvement over placebo. In addition, a strong safety profile for the product was observed.

Research shows harmful effects of chemicals in vaping liquids to lung tissue

New research appearing in the journal Scientific Reports unpacks the list of chemicals that comprise flavored e-liquids and pods used in vaping and details their harmful effects to lung tissue, including inflammation and genetic damage that could indicate long-term risk for respiratory disease and even cancer.

Read more Medical News

› Verified 2 days ago

Entity NameThe General Hospital Corporation
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1023049236
PECOS PAC ID: 6507803806
Enrollment ID: O20080313000351

News Archive

Researchers find potential therapeutic strategy to treat Alzheimer's

Researchers from the Institute of Neurosciences of the University of Barcelona (UBNeuro) have identified a potential therapeutic strategy to treat Alzheimer's, according to a study published in Journal of Neuroscience.

Different molecular mechanisms in suprachiasmatic nucleus linked to jet lag differences

It's no secret that long-distance, west-to-east air travel - Seattle to Paris, for example - can raise havoc with a person's sleep and waking patterns, and that the effects are substantially less pronounced when traveling in the opposite direction.

Canadian and Israeli researchers join forces for new research program

The Joint Canada-Israel Health Research Program is a seven-year, CA$35 million partnership between the Azrieli Foundation, Canada's International Development Research Centre, the Canadian Institutes of Health Research, and the Israel Science Foundation that draws on the scientific strengths of Canadian and Israeli researchers in the broad field of biomedicine.

Clonidine Topical Gel fails to meet primary endpoint in Phase 3 study for treatment of painful diabetic neuropathy

BioDelivery Sciences International, Inc. announced that the primary efficacy endpoint in the Phase 3 clinical study of Clonidine Topical Gel compared to placebo for the treatment of painful diabetic neuropathy did not meet statistical significance, although certain secondary endpoints showed statistically significant improvement over placebo. In addition, a strong safety profile for the product was observed.

Research shows harmful effects of chemicals in vaping liquids to lung tissue

New research appearing in the journal Scientific Reports unpacks the list of chemicals that comprise flavored e-liquids and pods used in vaping and details their harmful effects to lung tissue, including inflammation and genetic damage that could indicate long-term risk for respiratory disease and even cancer.

Read more Medical News

› Verified 2 days ago

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Michael L Blute is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing AddressPractice Location Address
Michael L Blute, MD
Po Box 9142,
Charlestown, MA 02129-9142

Ph: () -
Michael L Blute, MD
15 Parkman St, Wang 528,
Boston, MA 02114-3117

Ph: (617) 726-4530

News Archive

Researchers find potential therapeutic strategy to treat Alzheimer's

Researchers from the Institute of Neurosciences of the University of Barcelona (UBNeuro) have identified a potential therapeutic strategy to treat Alzheimer's, according to a study published in Journal of Neuroscience.

Different molecular mechanisms in suprachiasmatic nucleus linked to jet lag differences

It's no secret that long-distance, west-to-east air travel - Seattle to Paris, for example - can raise havoc with a person's sleep and waking patterns, and that the effects are substantially less pronounced when traveling in the opposite direction.

Canadian and Israeli researchers join forces for new research program

The Joint Canada-Israel Health Research Program is a seven-year, CA$35 million partnership between the Azrieli Foundation, Canada's International Development Research Centre, the Canadian Institutes of Health Research, and the Israel Science Foundation that draws on the scientific strengths of Canadian and Israeli researchers in the broad field of biomedicine.

Clonidine Topical Gel fails to meet primary endpoint in Phase 3 study for treatment of painful diabetic neuropathy

BioDelivery Sciences International, Inc. announced that the primary efficacy endpoint in the Phase 3 clinical study of Clonidine Topical Gel compared to placebo for the treatment of painful diabetic neuropathy did not meet statistical significance, although certain secondary endpoints showed statistically significant improvement over placebo. In addition, a strong safety profile for the product was observed.

Research shows harmful effects of chemicals in vaping liquids to lung tissue

New research appearing in the journal Scientific Reports unpacks the list of chemicals that comprise flavored e-liquids and pods used in vaping and details their harmful effects to lung tissue, including inflammation and genetic damage that could indicate long-term risk for respiratory disease and even cancer.

Read more News

› Verified 2 days ago


Urology Doctors in Boston, MA

Brian Howard Eisner, MD
Urology
Medicare: Accepting Medicare Assignments
Practice Location: 55 Fruit St, Massachusetts General Hospital, Boston, MA 02114
Phone: 617-726-3512    
Catherine Gu, MD
Urology
Medicare: Not Enrolled in Medicare
Practice Location: Bwh 75 Francis St, Boston, MA 02115
Phone: 617-732-5500    
Dr. Dianne E Sacco, MD
Urology
Medicare: Accepting Medicare Assignments
Practice Location: 55 Fruit St, Dept Of Urology, Boston, MA 02114
Phone: 617-726-3760    Fax: 617-726-6131
Peter Lang Steinberg, MD
Urology
Medicare: Accepting Medicare Assignments
Practice Location: 330 Brookline Ave, Bidmc Division Of Urology, Rabb 440, Boston, MA 02215
Phone: 617-667-3739    
Richard N Yu, M.D, PH.D.
Urology
Medicare: May Accept Medicare Assignments
Practice Location: 300 Longwood Ave, Department Of Urology, Hu-390, Boston, MA 02115
Phone: 617-355-7796    
Dr. Quoc-dien Trinh, M.D.
Urology
Medicare: Accepting Medicare Assignments
Practice Location: 45 Francis St, Division Of Urology, Boston, MA 02115
Phone: 617-525-7350    
Dr. Melise A Keays, MD
Urology
Medicare: Medicare Enrolled
Practice Location: 300 Longwood Ave, Boston, MA 02115
Phone: 617-355-6000    

Find & Compare Providers Near You: Find and compare doctors, nursing homes, hospitals, and other health care providers in your area that accept Medicare. Get information like: Find a doctor or clinician that accepts Medicare near you.

Doctors and clinicians: Doctors and clinicians include doctors, clinicians and groups who are qualified to practice in many specialties. Each specialty focuses on certain parts of the body, periods of life, conditions, or primary care. The doctors, clinicians, and groups listed here typically work in an office or clinic setting. Also those who currently accept Medicare are included.

Hospitals: Find information about Medicare-certified hospitals and long-term care hospitals in your area, including Veterans Administration medical centers and military hospitals, across the country. Long-term care hospitals serve critically ill and medically complex patients who require extended hospital care.

Data provided: Information on www.medicareusa.org is built using open data sources published by Centers for Medicare & Medicaid Services (CMS) under Freedom of Information Act (FOIA).

© 2024 MedicareUsa. All rights reserved. Maintained by the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.